Biotechnology Assets, S.A. (BST:041)
Germany · Delayed Price · Currency is EUR 0.1800
-0.0300 (-14.29%)
At close: Dec 5, 2025
Biotechnology Assets Market Cap
Biotechnology Assets has a market cap or net worth of €19.54 million as of December 5, 2025. Its market cap has decreased by -6.70% in one year.
Market Cap
19.54M
Enterprise Value
21.10M
Revenue
3.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.18
Market Cap Chart
Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 19.54M, a decrease of -73.83%. That is a compound annual growth rate of -16.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 19.54M | 6.88% |
| Dec 31, 2024 | 18.28M | -20.03% |
| Dec 29, 2023 | 22.86M | 84.02% |
| Dec 30, 2022 | 12.42M | -40.67% |
| Dec 30, 2021 | 20.94M | -3.86% |
| Dec 31, 2020 | 21.78M | -72.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 177.09B |
| Allianz SE | 138.86B |
| Deutsche Telekom AG | 129.48B |
| Siemens Energy AG | 97.17B |
| Rheinmetall AG | 69.69B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.36B |
| Deutsche Bank Aktiengesellschaft | 58.36B |